All
News
Media Coverage
Events
LumiraDx to Announce Fourth Quarter and Full Year 2022 Financial Results and Host Quarterly Conference Call on March 21 2023
2023/03/14
DELAB conference 2023
2023/04/13
Mainz, Germany
Worldlab – Euromedlab Roma 2023
2023/05/21
Roma, Italy
The 33rd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
2023/04/15
Denmark
LumiraDx Receives FDA Emergency Use Authorization and UK CTDA Approval for its Fast Lab Solutions Multiplex COVID and Influenza Molecular Assay
2023/02/06
LumiraDx Announces Commercial Shipment of its Point of Care NT-proBNP Test in Europe, Supporting Heart Health Checks in UK
2023/01/31
NHS Confederation Primary Care Network Conference 2023
2023/02/22
UK
Best Practice London 2023
2023/03/08
POCT: The Power to Disrupt 2023
2023/03/28
P4H Scotland 2023
2023/04/19
Infection Prevention and Control 2023
2023/04/25
32nd Annual Meeting of the Society for Virology
Ulm, Germany
Deutscher Labortag (BDL Annual Meeting)
2023/03/23
Berlin, Germany
4th Annual Infectious Disease and Molecular Diagnostics Conference 2023
MEDIZIN 2023
2023/02/03
Messe Stuttgart, Germany
Medlab Middle East
Dubai
LumiraDx latest cost reduction program continues progress toward operating cash flow breakeven by the end of 2023
2022/12/19
LumiraDx Receives CTDA Approval for its LumiraDx Dual-Target SARS-CoV-2 STAR Complete
2022/12/15
LumiraDx Announces New Investment for Ongoing Development of its Point of Care Molecular Tuberculosis Test
Health Tech World: Driving change in healthcare using point-of-care diagnostics
2022/12/14
Lab Pulse: Bill & Melinda Gates Foundation awards $14.2M in grants to LumiraDx to develop TB testing system
129th DGIM Annual Congress (Jahrestagung der Deutschen Gesellschaft für Innere Medizin, DGIM e.V.)
2023/04/22
RheinMain CongressCenter / Wiesbaden, Germany
18. Jahrestagung Deutsche Gesellschaft Interdisziplinäre Notfall- und Akutmedizin (DGINA) e.V.
2023/05/04
Bielefeld, Germany
DDG Annual Meeting (Jahrestagung der Deutschen Diabetes Gesellschaft, DDG e.V.)
2023/05/17
CityCube Berlin, Germany
Practitioner's Medical Congress Quadrimed
2023/01/26
Congress Center «Le Régent», Crans-Montana, Switzerland
25. Kardiologie Kongress Innsbruck
2023/06/29
Innsbruck, Austria
62nd Medical Congress Davos (Ärztekongress des Verein Lunge Zürich)
2023/02/09
Congress Center Davos , Switzerland
39th spring conference of the ÖDG (Austrian Diabetes Society)
2023/05/11
ÖIK - Österreichischer Infektionskongress
2023/03/21
Saalfelden, Austria
46th Medical Congress Arosa (46. Ärztekongress Arosa)
2023/03/24
Arosa, Switzerland
11th Eastern Swiss emergency symposium (11. Ostschweizer Notfallsymposium)
2023/03/30
St. Gallen, Switzerland
25th CMPR Continuing Education Symposium
2023/06/15
Lausanne, Switzerland
Joint Annual Meeting 2023 of the Swiss Society of Cardiology (SSC), the Swiss Society of Cardiac Surgery (SSCS), the Swiss Society of Pneumology (SSP) and the Swiss Society of Thoracic Surgery (SSTS)
2023/06/21
Basel, Switzerland
KHM-Congress 2023 (Kollegium für Hausarztmedizin)
2023/06/22
Luzern, Switzerland
7th SGAIM Spring Congress (Frühlingskongress der Schweizerischen Gesellschaft für Allgemeine Innere Medizin, SGAIM)
2023/05/10
Annual Meeting of the German Respiratory Society DGP e.V. (Jahrestagung der Deutschen Gesellschaft für Pneumologie, DGP e.V.)
2023/03/29
Duesseldorf, Germany
19th VERAH Congress Soltau
2023/04/14
Soltau, Germany
Latest Clinicians’ U.S. Survey Identifies Point of Care Testing (POCT) as a Way to Address Healthcare Bandwidth Pressures and Anticipates Future Growth of POCT in Community Testing Centers
2022/12/08
Clinical Services Journal: Adopt point of care testing to cut carbon emissions, say over 80% of GPs
ET Health World: LumiraDx launches C-Reactive Protein test to combat antimicrobial resistance in India
2022/11/24
LumiraDx Continues Commercial Expansion of its Rapid Microfluidic Immunoassay HbA1c Test
2022/11/14
Health Tech World: LumiraDx continues expansion of HbA1c test
LumiraDx Reports Third Quarter 2022 Results
2022/11/09
Supporting antimicrobial stewardship using point of care CRP testing
2022/11/22
Online Webinar
51st SVA Davos Congress 2022 (Schweiz. Verband Medizinischer Praxis-Fachpersonen)
2022/11/04
Switzerland
52. Kongress für Allgemeinmedizin
Austria
13th Annual Meeting of the Austrian Association for Emergency Medicine (AAEM)
Vienna, Austria
DDG Autumn Conference (Herbsttagung der Deutschen Diabetes Gesellschaft, DDG e.V.)
2022/11/25
Germany
LumiraDx named by Frost & Sullivan as the 2022 Europe Technology Innovation Leader in the Microfluidics Point of Care Diagnostics Industry
2022/10/12
54th Brazilian Congress of Clinical Pathology/Laboratory Medicine
2022/10/04
Brazil
Health Europa: Diagnostic technology is central to tackling pandemics
2022/09/22
LumiraDx Partners with British In Vitro Diagnostics Association to Report on the Role of Rapid Diagnostics in Tackling Antimicrobial Resistance
Medical Product Outsourcing: Integrating Point of Care to Future Proof our Community Health System
2022/09/16
LumiraDx Awarded Rapid Testing Agreement with Premier, Inc.
2022/09/08
KevinMD: Immediate, accurate diagnosis is crucial to the future of equitable patient care
2022/08/29
Health Tech World: LumiraDx COVID-19 antigen test alone in exceeding WHO target in Cochrane Review
2022/08/25
Health Europa: LumiraDx’s COVID-19 antigen test is the only test exceeding WHO’s desirable sensitivity target
MEDICA – World Forum for Medicine
Düsseldorf, Germany
LumiraDx Reports Second Quarter 2022 Results
2022/08/18
LumiraDx Announces Pricing of Public Offering of Common Shares and Concurrent Private Placement
2022/07/21
LumiraDx to Present on Impact of its Next-Generation Microfluidic Technology at American Association for Clinical Chemistry (AACC) Annual Conference in Chicago
2022/07/25
LumiraDx Announces Proposed Public Offering of Common Shares
2022/07/19
Nordcoag 2022
2022/08/31
Iceland
London Loves Business: Groundbreaking Covid test gives lifeline to businesses as cases soar
2022/06/30
HealthTech World: The versatile diagnostic platform that passes the test
2022/06/14
LumiraDx Receives CE Mark for Two Multiplex Tests: LumiraDx Dual-Target SARS-CoV-2 STAR Complete and LumiraDx SARS-CoV-2 & Flu A/B RNA STAR Complete
2022/06/08
LumiraDx Expands its Cardiovascular Testing Portfolio with CE Marking of its NT-proBNP Test and new Exclusion Claim for its D-Dimer Test
2022/06/02
360Dx: LumiraDx Gets New, Expanded CE Marks for Point-of-Care Cardiovascular Disease Tests
LumiraDx HbA1c Test Achieves CE Mark, Addresses Growing Global Need for Diabetes Screening and Monitoring with its Next-Generation Point of Care Diagnostic Platform
2022/05/26
Medical Device Network: LumiraDx’s HbA1c test receives CE mark for diabetes screening
HealthTech World: LumiraDx receives WHO Emergency Use Listing for SARS-CoV-2 Ag Test
MD+DI: LumiraDx Scores CE Mark for Fast POC COVID-19 Test
2022/05/24
LumiraDx Receives WHO Emergency Use Listing for SARS-CoV-2 Ag Test
2022/05/20
LumiraDx Five-Minute SARS-CoV-2 Ag Ultra Test Achieves CE Marking
2022/05/19
HealthTech World: Antimicrobial resistance: New guidance on using CRP tests in primary care to reduce antibiotic overprescribing
2022/05/18
Annual conference paediatrics switzerland 2022 (Jahrestagung pädiatrie schweiz 2022)
Annual Meeting of the Swiss Society for Clinical Chemistry (SSCC)
2022/09/14
Olma St. Gallen, Switzerland
ÖGARI (Austrian Society for Anaesthesiology, Resuscitation and Intensive Care Medicine)
2022/10/01
St. Gilgen, Austria
LumiraDx Reports First Quarter 2022 Results
2022/05/11
Bill Gates Ted Talk: We Can Make COVID-19 the Last Pandemic | Bill Gates | TED
2022/04/29
Health Europa: Answering healthcare needs with point-of-care testing
2022/04/26
Forbes: Could The Innovation Stack Revolutionize Your Industry?
2022/04/15
Fast Company: Bill Gates wants to create a global pandemic first response team
2022/04/12
6th SGAIM Autumn Congress (Herbstkongress der Schweizerischen Gesellschaft für Allgemeine Innere Medizin, SGAIM)
Davos, Switzerland
LumiraDx Reports Fourth Quarter and Full Year 2021 Results
2022/03/10
SeaTrade Cruise Global 2022
Miami Beach, FL USA
USCAP 2022
2022/03/23
Los Angeles, CA, USA
LumiraDx Announces Pricing of $56.5 Million Convertible Notes Offering
2022/03/01
LumiraDx Receives UK MHRA Approval for SARS-CoV-2 RNA STAR Complete
2022/02/21
Health Europa: LumiraDx: Fighting antimicrobial resistance with innovative POC testing
2022/01/26
HICC Workshop 2022
LumiraDx Lab Analysis Confirms its COVID-19 Antigen Test Detects the Omicron Variant
2022/01/14
XLIX Congresso Nazionale AMCLI
2022/02/26
Italy
LumiraDx CRP Test Achieves CE Marking
2022/01/11
LumiraDx has Commenced Shipments in Europe for its COVID-19 & Flu A/B MicrofluidicAntigen Test
NHS ConfedExpo 2022
2022/06/15
IBMS 2022
2022/03/14
The Pharmacy Show 2022
2022/10/16
International Society on Thrombosis and Haemostasis (ISTH) 2022 Congress
2022/07/09
3rd Annual Infectious Disease Diagnostics and Molecular Diagnostics Conference 2022
The 24th IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine - EuroMedLab
2022/04/10
LumiraDx COVID-19 & Flu A/B Rapid Antigen Test Achieves CE Marking
2021/12/23
LumiraDx Fast Lab Solutions Partners with Audere for At-Home Self- Collection Solution for use with SARS-CoV-2 RNA STAR Complete
2021/12/15
FDA Reissues LumiraDx Fast Lab Solutions’ EUA for SARS CoV-2 RNA STAR Complete Molecular Reagents to Allow High Throughput and Asymptomatic Testing Solutions
2021/12/01
AACC 2022
2022/07/24
USA
LumiraDx Monitoring of New and Emerging Variants of Concern and Detection of the Omicron Variant
2021/11/29
Scientific Spring Meeting KNVM & NVMM 2022
2022/04/05
Netherlands
SSM Annual Meeting and Assembly 2022 (Swiss Society for Microbiology)
2022/08/30
51st BVKJ Annual Meeting (German Association of Pediatricians e.V.)
2022/06/17
LumiraDx Reports Third Quarter 2021 Financial Results
2021/11/10
88th DGK Annual Congress 2022
2021/04/20
5th Munich POCT Symposium (5. Münchner POCT-Symposium)
2022/09/27
11. JHaS Congress
2022/04/08
Labquality Days
2022/04/20
Finland
LumiraDx receives approval for its COVID-19 Antigen Test for use in India
2021/10/20
LumiraDx Announces FDA EUA Submission for its SARS-CoV-2 & Flu A/B Rapid Antigen Test
2021/10/15
360Dx: Post-IPO, LumiraDx Pushes Adoption of POC Instrument, Eyes Test Menu Expansion
2021/10/07
360Dx: Point-of-Care Test Developer LumiraDx Goes Public on Nasdaq
2021/09/29
LumiraDx to Become Publicly Traded following Successful Closing of Merger with CA Healthcare Acquisition Corp.
2021/09/28
Bill & Melinda Gates Foundation’s Goalkeepers report features LumiraDx’s work in the fight against COVID-19
2021/09/21
10th Eastern Swiss Emergency Symposium
2022/09/28
34th World Congress of Biomedical Laboratory Science
2021/08/28
Copenhagen
LumiraDx and CA Healthcare Acquisition Corp Revise Transaction Terms, Expanded Strategic Roadmap for Next-Generation Point-of-Care Diagnostics
2021/08/20
PLOS Medicine publishes systematic review and meta-analysis of more than 60 SARS- CoV-2 antigen tests: Ranks LumiraDx’s SARS-CoV-2 Ag Test as most sensitive and accurate
2021/08/18
11th ARAM Romand Congress
Montreux, Switzerland
German Company Doctors Congress 2022 (Deutscher Betriebsärzte Kongress 2022)
2022/10/06
Weimar, Germany
Diagnostics-4-Future Conference 2022
Konstanz, Germany
Deutscher Kongress für Laboratoriumsmedizin, DKLM
2022/10/13
Mannheim, Germany
47. practica
2022/10/19
Bad Orb, Germany
32. Grazer Fortbildungstage der Ärztekammer für Steiermark
Graz, Austria
Swiss Symposium in Point of care Diagnostics
2022/10/20
IFAS 2022
2022/09/25
Zürich, Switzerland
DGK Heart Days (Herztage der Herz- und Kreislaufforschung, DGK e.V.)
2022/09/29
World Conference Center Bonn, Germany
LumiraDx Receives FDA Emergency Use Authorization for its COVID-19 Antibody Test, Now Allowing COVID-19 Antigen and Antibody Testing on a Single Point of Care Platform
2021/08/05
LumiraDx Achieves CE Mark for Its High Sensitivity, High Throughput COVID-19 Molecular Test, RNA STAR Complete
2021/07/02
LumiraDx High Sensitivity Point of Care Antigen Test Detects Against Leading Variants of Concern including Alpha, Beta, Gamma, and Delta
2021/06/24
LumiraDx Announces Commercial Launch of its SARS-CoV-2 Ag Pool Test in CE Mark countries
2021/06/17
Shionogi Announces Agreement of Joint Sales with LumiraDx Japan for Novel Coronavirus Antigen test agent and diagnostic instrument in Japan
2021/04/21
Bloomberg: Test Maker LumiraDx to Go Public in $5 Billion SPAC Deal
2021/04/06
Procurex Scotland
2020/10/27
Online
RCGP Annual Primary Care Conference & Exhibition
2021/02/11
LumiraDx Launches first-of-its-kind smart Diagnostic platform
2019/08/29
Supporting healthier lives, for individuals, communities and wider society
Enabling responsive, personal relationships between patients and care teams.
Controlling and reducing costs to help ease pressure on healthcare budgets.